OREXIGEN THERAPEUTICS INC's ticker is OREXQ and the CUSIP is 686164302. A total of 53 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 17.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $465,000 | -83.8% | 2,226,839 | 0.0% | 0.00% | -85.7% |
| Q4 2017 | $2,873,000 | -39.1% | 2,226,839 | 0.0% | 0.03% | -52.5% |
| Q3 2017 | $4,721,000 | -26.9% | 2,226,839 | 0.0% | 0.06% | -20.3% |
| Q2 2017 | $6,458,000 | -15.7% | 2,226,839 | 0.0% | 0.07% | -17.8% |
| Q1 2017 | $7,660,000 | +97.7% | 2,226,839 | 0.0% | 0.09% | +76.5% |
| Q4 2016 | $3,875,000 | -47.6% | 2,226,839 | 0.0% | 0.05% | -51.4% |
| Q3 2016 | $7,393,000 | – | 2,226,839 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 734,976 | $2,440,000 | 0.46% |
| Baupost Group | 2,226,839 | $7,393,000 | 0.10% |
| Rhenman & Partners Asset Management AB | 120,000 | $398,400,000 | 0.06% |
| NEA Management Company, LLC | 370,900 | $1,231,000 | 0.06% |
| SAMLYN CAPITAL, LLC | 616,040 | $2,046,000 | 0.05% |
| Rock Springs Capital Management LP | 165,300 | $549,000 | 0.03% |
| Palo Alto Investors LP | 167,302 | $555,000 | 0.03% |
| Telemetry Investments, L.L.C. | 10,250 | $34,000 | 0.02% |
| TWO SIGMA SECURITIES, LLC | 10,478 | $35,000 | 0.01% |
| PDT Partners, LLC | 29,800 | $99,000 | 0.01% |